BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12908033)

  • 1. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice.
    Silva LM; Menezes RM; de Oliveira SA; Andrade ZA
    Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
    Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
    Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
    Bonesso-Sabadini PI; de Souza Dias LC
    Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
    Panic G; Ruf MT; Keiser J
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
    Araujo N; Mattos AC; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment of Biomphalaria glabrata infected by Schistosoma mansoni with oxamniquine and praziquantel: Reproductive histological and metabolic aspects.
    Lima RN; Coelho PMZ; Mattos ACA; Mello Silva CC; Augusto RC; Mota EM; de Souza S; Atella GC; Cabral SS; Gabriel Kluck GE; Faro MJ
    Exp Parasitol; 2017 Dec; 183():6-12. PubMed ID: 29017937
    [No Abstract]   [Full Text] [Related]  

  • 9. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):352-7. PubMed ID: 3589395
    [No Abstract]   [Full Text] [Related]  

  • 11. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of Schistosoma mansoni progeny to antischistosomal drugs.
    Dias LC; Olivier CE
    Rev Inst Med Trop Sao Paulo; 1985; 27(4):186-9. PubMed ID: 3832339
    [No Abstract]   [Full Text] [Related]  

  • 13. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
    Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
    Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
    Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
    Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of oxamniquine on Schistosoma mansoni: some biological and biochemical observations.
    Goldberg M; Gold D; Flescher E; Lengy J
    Biochem Pharmacol; 1980 Mar; 29(5):838-40. PubMed ID: 20227968
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantel.
    Liang YS; Coles GC; Doenhoff MJ; Southgate VR
    Int J Parasitol; 2001 Sep; 31(11):1227-35. PubMed ID: 11513892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study.
    Lamberton PHL; Faust CL; Webster JP
    Infect Dis Poverty; 2017 Jun; 6(1):110. PubMed ID: 28622767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in schistosomiasis.
    Coles GC; Bruce JI; Kinoti GK; Mutahi WT; Dias EP; Katz N
    Trans R Soc Trop Med Hyg; 1986; 80(2):347. PubMed ID: 3787696
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
    Fallon PG; Hamilton JV; Doenhoff MJ
    Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.